National Industries Company - KPSC (KWSE:NICBM)

Aerovate Therapeutics Balance Sheet

Financials in millions KWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	2.74	2.98	2.85	3.61	8.8	7.33
Short-Term Investments	12.3	16.8	20.05	12.55	6.05	5.9
Trading Asset Securities	3.32	3.11	2.81	3.02	3.05	2.15
Cash & Short-Term Investments	18.36	22.88	25.71	19.18	17.9	15.38
Cash Growth	-5.65%	-10.99%	34.03%	7.13%	16.42%	24.89%
Accounts Receivable	13.99	8.32	9.96	9.75	7.07	9.21
Other Receivables	1.8	3.39	2.86	3.14	2.48	1.51
Receivables	15.78	11.72	12.82	12.89	9.55	10.72
Inventory	24.96	24.38	22.89	25.83	24.04	22.36
Prepaid Expenses	-	1	1.08	0.69	0.54	0.58
Other Current Assets	-	1.11	0.28	1.12	4.3	6.35
Total Current Assets	59.11	61.08	62.78	59.72	56.33	55.38
Property, Plant & Equipment	21.53	19.44	20.9	22.63	24.43	27.19
Long-Term Investments	25.99	28.67	25.37	26.45	30.5	30.89
Other Long-Term Assets	13.99	14.01	8.68	8.6	8.35	4.8
Total Assets	120.62	123.2	117.72	117.39	119.61	118.26
Accounts Payable	17.85	4.22	5.49	5.39	3.41	7.24
Accrued Expenses	-	8.09	7.1	5.64	5	4.49
Short-Term Debt	1.56	2.21	0.95	0.8	1.53	1.4
Current Portion of Leases	0.7	0.59	1.48	1.07	1.01	1.48
Current Unearned Revenue	-	0.07	0.04	0.07	0.15	0.27
Other Current Liabilities	-	4.95	7.51	7.16	6.74	4.59
Total Current Liabilities	20.11	20.12	22.57	20.13	17.84	19.47
Long-Term Leases	2.75	0.62	0.16	1.2	2.02	3.01
Other Long-Term Liabilities	0.56	0.56	0.55	0.55	0.53	0.51
Total Liabilities	31.57	29.34	30.69	29.25	27.55	29.96
Common Stock	35.09	35.09	35.09	35.09	35.09	35.09
Additional Paid-In Capital	32.57	32.57	32.57	32.57	32.57	32.57
Retained Earnings	14.11	16.04	12.62	11.88	11	6.6
Treasury Stock	-0.85	-0.3	-0.17	-0.22	-0.24	-0.25
Comprehensive Income & Other	7.07	9.63	5.49	7	10.14	10.26
Total Common Equity	87.99	93.03	85.59	86.31	88.56	84.26
Minority Interest	1.06	0.84	1.44	1.83	3.51	4.05
Shareholders' Equity	89.05	93.87	87.03	88.14	92.06	88.31
Total Liabilities & Equity	120.62	123.2	117.72	117.39	119.61	118.26
Total Debt	5.01	3.41	2.59	3.07	4.55	5.9
Net Cash (Debt)	13.36	19.47	23.12	16.11	13.35	9.48
Net Cash Growth	-8.31%	-15.77%	43.48%	20.71%	40.82%	-6.90%
Net Cash Per Share	0.04	0.06	0.07	0.05	0.04	0.03
Filing Date Shares Outstanding	346.81	349.14	359.23	359.12	358.92	349.63
Total Common Shares Outstanding	346.81	349.14	359.23	359.12	358.92	349.63
Working Capital	39	40.96	40.21	39.58	38.49	35.91
Book Value Per Share	0.25	0.27	0.24	0.24	0.25	0.24
Tangible Book Value	87.99	93.03	85.59	86.31	88.56	84.26
Tangible Book Value Per Share	0.25	0.27	0.24	0.24	0.25	0.24
Buildings	-	33.98	33.79	33.67	33.3	33.21
Machinery	-	77.79	77.65	76.49	74.13	72.72
Construction In Progress	-	0.75	0.53	0.74	1.6	1.71

Updated Feb 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.